Deciphera Pharmaceuticals To Present At Future Leaders In The Biotech Industry Conference

WALTHAM, Mass.--(BUSINESS WIRE)--Deciphera Pharmaceuticals, a clinical-stage biotechnology company focused on advanced kinase inhibitor treatments targeting the tumor cell and the tumor microenvironment, today announced that Michael D. Taylor, Ph.D., Deciphera’s President and Chief Executive Officer will present a corporate update at the 22nd Annual Future Leaders in the Biotech Industry Conference on Friday, March 20, 2015 at 2:30 p.m. ET in New York.

Help employers find you! Check out all the jobs and post your resume.